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Introduction: Patient non-adherence to treatment is a major problem across most chronic
diseases. In COPD and asthma treatments it is a complex issue because people need to
make behavioral and lifestyle changes while taking medications. Poor adherence results in
increased rates of morbidity and mortality, more frequent hospitalizations, and ultimately
higher healthcare expenditures.
Materials and methods: The objective of the study was to assess asthmatic and
COPD patient’s attitudes toward adherence in Hungary. Health Belief Model was used
to help explain reasons of non-adherence. The results of the study should provide
additional support to understanding health-related behaviors and to developing health
related programs enhancing adherence of asthmatic and COPD patients.
145 diagnosed COPD patients and 161 diagnosed asthmatic patients were involved in
6 pulmonary centers. The questions were designed to measure Health Belief Model
dimensions A 1–5 point verbal Likert scale was used. As a second stage, the answers
were compared with the registered patient’s personal health data available in pulmonary
center’s documentation. The data was analyzed using SPSS software.
Results:More than 32% of patients are very interested in new asthma or COPD research
results, but their main information source is physician. The trust toward the physician
is very high. Patients accept treatments and rarely ask questions. Respondents are
cooperative but sometimes fail to follow therapeutic recommendations. There is no
willingness to join self-help groups or associations.
Discussion: The paternalistic approach was generally accepted, moreover expected by the
patients from the physicians. It is important to train patients, increase their self-efficacy,
responsibility and involve them into self-management programs. Both physicians and
patients should be trained how to communicate—this approach can lead to increased
understanding and better adherence.
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INTRODUCTION
WHO estimates that minimum 300 million people are affected
by asthma globally, while annual mortality is estimated to
be 250,000 (Global Initiative, 2012). Disease prevalence is
on the increase in most countries, mainly among chil-
dren. It is estimated that by 2025 the number of patients
might reach 400 million, despite the availability of effec-
tive and modern treatment methods in more and more
countries.
In Hungary, the prevalence of asthma is estimated to be
around 2–15%. The number of patients suffering from asthma in
the lungs increases year after year. According to the Hungarian
Statistical Bureau (KSH) the number of known and registered
patients was 128,809 in 2000, and as high as 223,376 in 2007 and
272883 in 2012 (Böszörményi et al., 2013).
Asthma is considered to be an under-diagnosed disease
(Nathan et al., 2004). As symptoms are non-specific, sometimes
the physician and the patient misinterpret the symptoms, consid-
ering them as originating from infection, and it is treated as such,
and that is why late diagnosis is frequent.
The pathophysiology, diagnostics, clinical treatment, thera-
peutic management and prevention of asthma is summed up in
every detail in an international consensus called GINA (2012,
Global Initiative for Asthma, www.ginasthma.org).
COPD is characterized by a slowly and gradually progress-
ing constriction of the airway and breathing dysfunction, which
are mostly irreversible (that is unlike in the case of asthma this
constriction in the airway will not be resolved but maximum
mitigated by bronchodilator or other treatment). In developed
industrial countries 4–7% of the population are affected by this
disease, and the prevalence is rising globally. According to aWHO
estimate made in 2007, 210 million people suffer from COPD.
Like asthma, COPD is also under-diagnosed, since the patients
are unaware of their risk factors and adapt slowly to their changes.
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If the current tendency continues, it is going to be the third death
cause by 2030 (with a mortality rate of 8.6%); although COPD
will move up “only” one level in the ranking list, but in the per-
centage ratios the increase in COPD mortality will be probably
the highest (3.6%).
Like for asthma, a global initiative also exists in the
case of COPD [GOLD (2013)—“Global Initiative for Chronic
Obstructive Lung Disease”] which was formed in 1998 and has
constantly published updated guidelines related to the diagnostics
and treatment of this disease (www.copdgold.com).
International and Hungarian studies (Bergquist and
Crompton, 2001; Herjavecz et al., 2003) led to the conclu-
sion that despite the state-of-the-art medicinal treatment options
currently available, the treatment goals have not been met
for most of the patients. Only 20–30% of the patients are
controlled and approx. the same ratio (20–30%) are partially
controlled, that is the number of uncontrolled patients based
on the clinical symptoms can be estimated as representing
40–60%.
This high level of non-control can be explained partly by the
fact that patient adherence to medications is inadequate However,
adherence is not a stand-alone phenomena and should be investi-
gated in the context of doctor-patient communication (Zolnierek
and DiMatteo, 2009).
Studies indicate that many patients do not take the medication
as prescribed (Rand et al., 1992; Bosley et al., 1995; Clark et al.,
1999) and non-adherence to treatment is a cause of mortality and
morbidity in asthma.
Because of the magnitude of non-adherent behavior in asthma
and COPD there is an interest to find out:
• whether patient adherence in the case of asthma and COPD
will be influenced by the patients’ perception and opinion on
the severity of illness
• which are the main factors influencing the patient adherence
and the attitude toward therapy
• which are the main barriers for better patient adherence
• which are the opportunities of doctor-patient communication
enhancing patient adherence.
MATERIALS AND METHODS
THE THEORETICAL FRAMEWORK OF THE RESEARCH: THE HEALTH
BELIEF MODEL
Fundamentally, the purpose of this model is to explain the choice
of health behavior and the probability of choosing a healthcare
related form of behavior (Rosenstock, 1974; Becker et al., 1978;
Kotler and Clarke, 1987).
The model is built on the general assumption that people are
willing to do something for the assessment, screening and control
of their health condition and disease prevention if they consider
themselves susceptible to a disease and consider the disease severe
and threatening, and if they think that there are certain actions
with which the risk of catching that disease can be reduced and
that the time and/or financials spent on such action is com-
pensated for by the outcome resulting from not catching the
disease.
The basic variable categories of the model:
Perceived susceptibility
Subjective risk connected to a given health-related circumstance
or disease as perceived by the individual. In the case of physician-
diagnosed diseases it contains factors related to susceptibility
associated with the diagnosis, the personal conviction meaning
the probability attributed by the individual to his/her recovery
and in general with the disease.
Perceived severity
Emotions describing how severe the individual perceives the con-
dition associated with the given disease, including health risks
related to hospital and other medical treatment (pain, death, dis-
ability), and social risks as well (working ability, family life, social
relationships).
Perceived benefits
A benefit can be attributed to the action based on our percep-
tion of the action that can be done in relation to the susceptibility
to the given disease: if we believe that effective preventive mea-
sures can be taken, then there exists a perceived health benefit for
us. A different type of benefit may also be associated with a pre-
ventive action, for instance quitting smoking can mean financial
savings too.
Perceived barriers
A disease preventing action might have perceived disadvantages,
too, which may prevent the completion of the recommended
action. There might be several preventive factors that often are
not consciously described by the patient, but which may be felt
regarding an action, for instance that it is certainly expensive, or
that the action could be dangerous, there may be adverse effects,
and it could be unpleasant, painful, time-consuming and other
similar anxieties. According to Rosenstock (1974) it is the effect
of benefits following the joint consideration of susceptibility and
perceived ‘severity’ that gives the energy and urge for the desired
action.
Cues to actions
Several different opinions have evolved regarding these factors
that trigger action. Such a factor could be some kind of a physical
condition change or an impact from the environment, or perhaps
an effect communicated by the media. Few empirical studies have
been conducted regarding these cues and their impact.
Other variables
Socio-demographic and structural variables may influence indi-
vidual perception and this might have an indirect impact on
health related behavior.
Self efficacy
The conviction that the action, with which good results can
be achieved, can be performed successfully (Bandura, 1977;
Rosenstock et al., 1988) suggested that the original model should
be supplemented to include the belief in self efficiency, action
efficacy, as a separate construction.
Patient adherence to asthma therapy can be influenced by sev-
eral factors, which are complex and involve psychological, social
and medical issues (Clark et al., 1999). Based on the fact that
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few data are available to show the effect of psychological fac-
tors on patient adherence to asthma treatment (Clark et al.,
1999) and patient adherence is influenced by the attitude of the
patients, it is suggested to apply psychological models to explain
the connection between adherence and attitude.
One of the best known and recommended psychological mod-
els is the Health Belief Model, it was originally formulated to
explain specific forms of behavior related to health, in which pre-
dominantly cognitive variables had been included. In order to
make someone change (mostly through a single action) his/her
health-related behavior in this perspective, usually threats were
applied, attempting to influence the intellect by explaining what
threats the individual would face if he/she did not participate
in the given action. However, given the changed problems, the
method of communication should also be reasonably changed,
and encouragement is just as important as the explanation of the
risks. This means explaining the benefits that the individual will
enjoy once he/she managed to change his/her behavior, and this
communication could involve many emotional elements, too.
The HBM has provided a useful theoretical framework for
investigators of the cognitive determinants of a wide range of
behaviors for more than thirty years. The model’s common sense
constructs are easy for non-psychologists to assimilate and can be
readily and inexpensively operationalized in self-report question-
naires (Abraham and Sheeran, 2008).
EMPIRICAL STUDY
Similarly to international studies using the Health Belief Model
(Clark, 1999; Howell, 2008), we used this model as a framework in
our empirical research, too, as the questionnaire was formulated
based on the model variable.
The primary objective of this empirical research has been the
study of the disease related behavior and perception of asthmatic
and COPD patients based on the HBM. In our study, the subjec-
tive judgment and opinion of the patients were compared with
the data of paper-based documentation (source documentation)
available in healthcare institutions.
Our study aims included exploring whether the patients pre-
ferred the unconditional acceptance and performance of the
recommended therapy or and acceptance and adherence based
on agreement. Our goal was to find the possibilities that are avail-
able for more efficient patient information and patient education,
as well as those that facilitate the dialogue between the chronic
patient and his/her treatment physician.
RESEARCH METHODOLOGY
The research included survey among asthmatic and COPD
patients with a self-administered questionnaires. Questionnaires
were asked in six out of the seven pulmonary centers of the
country, and the target was 30 asthmatic and 30 COPD patient
questionnaires per center. Finally, we gathered 163 completed
(and evaluable) asthmatic and 147 completed (and evaluable)
COPD questionnaires. We chose the pulmonary centers because
we can find there the chronic patients and the best administered
dossiers of patient data. The doctors in the centers were ready
to help with additional information when it was needed to the
comparison of registered and self-administered survey data.
The samplingmethodwas convenience sampling, we could not
use a statistical method and the quotas in each center were equal,
they were not based on the prevalence data in the population. We
chose this method because of the lack of regional prevalence data.
This has been a retrospective, quantitative, single cross-sectional
study, without follow-up on the patient and without involving a
later prospective section. The target population consisted of men
and women aged 18 and above with registered bronchial asthma
or COPD diagnosis, receiving care in the given lung center.
The contents of the questionnaires practically matched for the
two patient groups, the differences originated mainly from the
different ethiologies of the diseases and the names of the diseases.
For easier distinction, the questionnaires of the two groups were
printed on sheets of different color.
In the case of asthma, the key pillars of diagnosis are the
clinical symptoms, the physical examination, the breath test
and the allergy status. In our empirical study we will use from
among the dynamic air volumes one of the most often mea-
sured parameter, the FEV11 value. According to the latest GINA
recommendations it is not recommended for deciding on ther-
apeutic changes in the course of ongoing asthmatic treatments,
nevertheless, it preserved its value as a rating in the cross sec-
tional analysis of asthma patient groups in which the patients are
not prescribed regular inhalation treatment (or do not receive
such treatment regularly). According to the latest GINA rec-
ommendation, the purpose of asthma treatment is to achieve
control of the disease and to maintain such control, thus clinical
control should be the basis for treatment and not the sever-
ity of the disease. The table measuring the level of control over
asthma and reflecting the current approach is contained in the
Appendix A.
The role of spirometry is greater in COPD than in asthma.
The diagnosis and the current severity and prognosis are based
on the FEV1 measurement. FEV1 measurement is a reliable and
accepted method for evaluating airway obstruction. (For rating
severity, here again we will use the percentage value relative to the
“required” value).
The structure of the questionnaire followed the categories of
the “Health Belief Model.” The model has been used as the theo-
retical framework, the topics of the questionnaire are following
the categories of the model. Some categories contain validated
multi-item scales, some are described by statements and ques-
tions based on the results of own expert interviews. The validated
scales are based on Asthma Control Test, the test used in this
study can be found in the Appendix B. The Asthma Control Test
aims to reflect the multidimensional nature of asthma control
and to demonstrate the performance against criterion measures
of asthma control (Nathan et al., 2004). The asthma control test
1FEV1 (Forced Expiratory Ventilation) expresses in litres the volume of
exhaled air in the first second of a forceful exhalation started right after a
maximum inhalation. This value can also be expressed as a percentage, if
(in standardized tables) we look at where the currently measured value is
positioned (how many %) in comparison with the so-called “required” (or
“predicted normal”) value corresponding to the patient’s age, sex and height.
This percentage FEV1value (that is the FEV1value expressed as a ratio of the
“required” value) is used in the assessment of the clinical severity of asthma.
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applied to our database showed a high level of internal validity
(Cronbach alpha higher than 0.8).
Data gathering and field work were performed together
between November 2010 and March 2011.
The research consisted of two parts:
In the first part (primary research) we carried to and dis-
tributed the questionnaires in the six lung centers, outpatient
clinics where we previously had discussed with the head physician
the planned research work and where agreement was also given
to the conducting of such research. In some places the health-
care professionals (assistants) and the head physician distributed
the questionnaires among the locally registered and treated asth-
matic and COPD patients. Patients reported at the outpatient
clinic spontaneously, not in response to a call. Questionnaires
were filled voluntarily while waiting in the clinic.
The completed questionnaires could be assigned to the source
documents used by codes.
The studied variables recorded from the source documents
were these:
• date (year) of diagnosing the disease
• spirometry parameter (FEV1)
• treatment, medication prescribed by the treatment physician.
The comparison enabled to control the answers of the self-
administered survey with the registered data of the patient
dossiers and in some cases with the information of doctors.
RESULTS
The data are analyzed and the results are presented in a grouping
matching the variants of the Health Belief Model, regarding the
asthmatic and the COPD patients, including a comparison of the
two patient groups.
The analysis of data has been done with using mainly uni-
variate and bivariate statistical methods and for some variables
multivariatemethods as well.We investigated themeans and stan-
dard deviations for the description of the variables and categories.
For the analysis of relationship we used the cross-tabulation with
Chi-square test, the variance analysis (ANOVA) and the Pearson
correlation and linear regression models. For the comparison of
perceived data, mentioned in the self-administered survey and the
registered patient data we used the comparison assigned into cat-
egories “matching” and “perception is better” or “perception is
worst.”
THE SOCIO-DEMOGRAPHIC STATUS OF RESPONDENTS
The sample consists of 163 asthmatic respondents and 147
COPD-respondents. The distribution according to the gender of
respondents is not the same in the 2 sub-samples, in the COPD
sample there is no difference between the number of male and
female respondents, in the asthma sample the number of female
respondents is the double of the male respondents.
The 2 sub-samples are different according to the qualification
as well: in the COPD sub-sample there are significantly more
respondents with lower qualification degree.
In the distribution according to age there are significant differ-
ences as well: the number of COPD-respondents above 61 years is
approximately the double of the asthma-patients in the same age
category, and in the age category under 40 there are only a very
few COPD-patients.
In accordance with the age distribution of the respondents
there are significantly more patients retired among the COPD-
patients (Table 1).
PERCEIVED SUSCEPTIBILITY
Fifty-one percent of the asthmatic patients have been aware of
their disease for more than 10 years, 21% of them between 5 and
10 years and 28% have been aware of their asthma for less than 5
years. A comparison of the “patient date” indicated by the patient
and the date of the first asthma or COPD diagnosis as found in
the source document, i.e., the “control date” has revealed that the
patient and control dates matched in the ratio of 31.2%, while
60.3% of the patients have known about their asthmatic disease
from earlier, while in 8.5% of the cases the patient perceived time
was shorter than that suggested by the control date. Forty-five
percent of the COPD patients have been aware of their disease
for <5 years, 26% of them between 5 and 10 years and 29%
have been aware of their COPD for more than 10 years. When
comparing the patient and control data, the two dates matched
for 32.2% of the patients, and this ratio is very similar to that
of the asthmatic patients. Nearly 20% of the patients became
aware of their disease later than the control date and this ratio
is twice as high as in the case of asthmatic patients. Nearly 48%
of the COPD patients dated their disease earlier than the control
date.
A comparison of the “patient date” indicated by the patient
and the control diagnosis date reveals that 53.2% of asthmatic
patient started visiting a specialist later than the diagnosis date,
and in around 28% of the cases did the perceived and the control
date match. In the case of COPD patients, the perceived and the
control dates matched in the ratio of 31%, while for 46% of them
the difference showed that they had started visiting a specialist
earlier than when the disease was diagnosed.
Table 1 | Distribution of sample according to the socio-demographic






Univ., college degree 26 19
High school degree 65 38
Skilled worker 44 56
Primary school 25 34
AGE
–40 years 44 4
41–60 years 84 71
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PERCEIVED SEVERITY
The patients rated their own condition by answering the ques-
tions of the Asthma Control Test (in the case of COPD the use of
the asthma control test was arbitrary, as the application of the test
is not so much recognized as justified as in the case of asthma).
The observable results of a comparison of the subjective judg-
ment about the condition with the FEV data (Table 2) kept on
the case-sheets have confirmed those previous international and
Hungarian studies that found that 40–60% of asthmatic patients
were not controlled (here 63.4%). According to the results of
this survey altogether 7 patients said that their disease was con-
trolled. Among them in 6 cases the LF parameter also “confirmed”
this (mild asthma). Among the 36 partly controlled patients the
asthma was categorized as mild for 22 and moderate for 12 based
on the LF. Remarkably, among the patients who considered their
disease not controlled (altogether 85 of them) the distribution
of mild-moderate-severe cases was 1/3–1/3–1/3. As can be seen,
90% of all patients with severe asthma considered their disease
not controlled. This is not surprising. On the other hand, how-
ever, approximately half of all mild asthmatic patients think that
their disease is not controlled. 34% of them said it was partly con-
trolled and 9% considered their asthma controlled, that is held in
balance.
The number of not controlled patients is higher among the
COPD patients (75%) and only 1.6% (2 persons) feel their dis-
ease is fully controlled (true, they are not suffering from severe
COPD according to their breath function tests). Among the not
controlled patients the mild-moderate-severe COPD patients are
distributed almost equally. 84% of all severe COPD patients are
not controlled according to patient judgments (which is not sur-
prising), however, 75% ofmild rated COPD patients also consider
their disease uncontrolled.
PERCEIVED BENEFITS
Moving on to the questions related to the treatment and the
usefulness of the treatment, a comparison of the patient-listed
data pertaining to medical treatment with the control data gives
us a picture about whether the patient knows clearly the treat-
ment prescribed for him/her. In 84% of the cases the data of the
two sources matched, in other words the majority of the patients
knew correctly the products that are to be taken (naturally, by
this the patient did not say that he/she took all of them regularly
according to the prescription).
It seems from responses of asthmatic patients that most of the
patients know exactly why they need to take a certain medicine,
trust the treatment and judge it useful.
The previously obtained data that 63% of the patients do
not consider their asthmatic disease controlled or balanced con-
tradicts this result. Thus, something is not all right here. The
medicines are good, advanced, effective and the patients know
them, yet it seems that in the longer run they do not consider
them sufficient for bringing about long-term comfort. Long-term
comfort requires something more, i.e., a more active, more con-
scious participation, changing of the lifestyle (attitude), which
cannot be achieved always (35% of them admits not having suc-
ceeded in observing all of these despite all the good intentions).
The same comparison in the case of COPD patients shows that
94% of the patients knows exactly the type of medicine he/she
takes (or should take), which corresponds to the similarly high
ratio found in the case of asthmatic patients.
Half of the patients feel that they are perfectly effective and
the other half thinks the medicines they take are not perfectly
effective. From the medical perspective these responses seem
absolutely rational, and correlate well with the nature of this dis-
ease, because they show that COPD is an irreversible, progressing
disease, in which even the best medicines can only alleviate the
symptoms and the complaints, but cannot fully eliminate the
basic disease, i.e., the constriction of the airway.
Like in the case of asthmatic patients, here again the willpower
is insufficient for executing the lifestyle and way-of-living changes
proposed by the treatment physician.
PERCEIVED BARRIERS
The responses to this group of questions point out the gaps
in therapy-related adherence. What we have known from other
studies were confirmed in this one: approximately half of the
asthmatic patients sometimes miss a medicine (medicines) and
mainly because they forget to take it/them. Fear of addiction or
Table 2 | The perceived and observed condition in asthma and COPD.
Absolute value and %* ASTHMA** COPD
OBSERVED OBSERVED
PERCEIVED Mild Moderate Severe Total Mild Moderate Severe Total
Controlled 6 1 0 7 1 1 0 2
4.5 0.7 0 5.2 0.8 0.8 0 1.6
Partly controlled 22 12 2 36 8 14 1 23
16.4 9 1.5 26.9 6.4 11.2 0.8 18.4
Not controlled 33 22 30 85 30 43 21 94
24.6 16.4 22.4 63.4 24 34.4 16.8 75.2
*Number and percentages of respondents.
**In the case of asthmatic patient the correlation analysis with Chi square test was significant at 1% level of significance.
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side effects and neglecting the treatments because of this are not
common.
It seems that patients stick to the habit of meeting the treat-
ment physician regularly. They do not forget this, because this is
a single, infrequently recurring obligation that is easier to observe
than other requirements that (would) need to be fulfilled in the
long run, regularly, under any circumstances (e.g., medication).
Those who do not find regular check-up visits difficult at all
represent a high percentage. This high “willingness” could be
explained by the fact that 60% of the respondents were pen-
sioners. As a notable fact, relatively many of the respondents
mentioned long waiting in the outpatient clinic as an unfavor-
able factor that may detain them from regularly visiting their
specialist.
In this group of questions—that is in relation with adherence
to therapy and the barriers to it—similar results have been found
in the case of COPD patients, as in the case of asthmatic patients:
sometimes the COPD patients neglect taking their medicines and
many of them because they forget.
The number of those who see no barriers and difficulties at
all in going for check-ups occasionally is high, but this is not
accidental. The percentage of retired people is even higher (80%)
among these respondents.
CUES TO ACTIONS
It can be said of the asthmatic patients that—as they admit—they
use their inhalators with convincing ease (92% of the asthmatic
respondents and 90% of the COPD respondents told they are
sure they use the inhalators in the correct way). Similarly self-
confident responses were given regarding the familiarity with and
effectiveness of the medicine (92% of the asthmatic respondents
and 90% of the COPD respondents told they are familiar with the
effects of the medicines). The question is raised how the correct
use of the inhalator and the efficacy of the product are connected
in the thinking of the patient. Is the patient aware that the correct
use of the inhalator is naturally a pre-condition for product effi-
cacy, but at the same time it may happen that despite correct use
of the inhalator the product is insufficient or ineffective for the
patient?
It is not typical of the patients asked that they want to con-
sult (about 50% of the patients in both diseases) discuss with
the doctor the disease, the “empowered patient” is not com-
mon. Paternalism, convenient, passive reliance on the treatment
physician is powerfully present, so much that the patient expects
information mainly from the doctor. This attitude may be related
to the type of health care system in which the patients were social-
ized. For asthmatic patient, Internet plays an important role in
information gathering (Table 3).
COPD patients also state with convincing self-confidence that
they use their inhalators correctly. Paternalism is strongly present
among them as well. They are interested in everything that is
related to their disease, but they do not look up information inde-
pendently, “proactively,” as they expect their physician to inform
them on what he/she thinks is needed, because the doctor will
surely know better what the correct care for the patient is.
In the case of asthmatic patients having a say in the matter of
medication is more frequent, while COPD patients leave this fully
to their doctor.
In comparison with the asthmatic patient group the ratio of
Internet users is insignificant, thus reaching the COPD patients
is not the most effective through this channel. The role of writ-
ten and electronic press is not dominant, either, only the personal
relationship is important. This may be related to the higher
average age of the COPD patients.
It is equally surprising that (like asthmatic patients) they do
not prefer patient communities in gathering information and
exchanging of experience.
The extent to which asthmatic patients and COPD patients do
not seek patient community participation could be quite strik-
ing. An explanation for this could be that in the given healthcare
system few patient clubs can be found and the intention for
organizing patient communities and self-organization is also low.
SELF EFFICACY
The picture is varied in terms of attitudes, forms of behavior, own
efforts that the patient is willing to mobilize in order to achieve
greater health. Typically, the activities that require the least effort
are the most popular ones. It is much more comfortable to say
that I avoid stress than to take on a form of regular exercise,
although no great differences can be seen among the average
values of the responses (Table 4).
In case of a deteriorating condition, the certain point is the
doctor, and experimenting with other methods is not typical.
Table 3 | Information sources and commitment of patients.
% (n) Asthma COPD
ARE YOU INTERESTED IN THE LATEST RESEARCH RESULTS?
Extremely interested 19 (30) 20 (29)
Very interested 13 (20) 19 (27)
Interested 57 (91) 49 (69)
Not very interested 11 (20) 12 (20)
HOW DO YOU OBTAIN INFORMATION?
Personally from the treatment physician 40 (100) 64 (116)
At organized meetings/in the club 2 (5) 3 (5)
From the Internet 22 (56) 8 (15)
From flyers 11 (26) 8 (15)
From television, radio, newspaper 25 (63) 17 (32)
Table 4 | Efforts to maintain health.
Asthma (average COPD (average
value)* value)*
Less stressful lifestyle 3.49 3.53
Gave up smoking 3.42 3.23
Healthy nutrition 3.38 3.17
Taking vitamins 3.33 3.1
Reducing smoking 3.27 3.06
Controlled body weight 3.15 3.03
Exercise 3.06 2.88
No effort 1.85 2.1
Responses were given in a 5-point scale, where 5 meant fully agree, and 1
meant fully disagree. *Significance at 0.05 level.
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According to the literature the efforts to maintain the health
or level of condition of asthma or COPD have a correlation with
socio-demographic variables only in a few cases and do not have
any correlation in the most cases.
Regarding the gender of the respondents there are some differ-
ences between the attitude of men and women, but the relation-
ship is significant only for taking vitamins (women take vitamins
according to more respondents) and for controlled body weight
(women control the body weight rather than men) (Table 5).
According to the age of the respondents there are some differ-
ences in the case of some factors, but the relationship is significant
only for the less stressful lifestyle (Table 6).
The condition of disease could have an effect on the behav-
ior how the patients try to maintain the level of disease and
try to avoid the deteroriation of the condition. According to
our research there are some differences in behavior depending
the perceived level of asthma or COPD, but the differences are
significant only in few cases (Table 7).
DISCUSSION
In this study, our purpose has been to explore the factors that
obstruct adherence and any implications to possible actions
related to them.
FACTORS AND EFFECTS OF PERCEIVED THREAT
The result that ∼2/3 of the patients have been aware of their asth-
matic disease and close to half of them of their COPD from earlier
than the control date raises the question what the patient really
considers as a disease, what he/she perceives as a disease. It might
Table 5 | Efforts to maintain health according to the gender of
respondents.
Asthma COPD
Less stressful lifestyle Male 3.32 3.67
Female 3.59 3.38
Gave up smoking Male 3.30 3.39
Female 3.50 2.70
Healthy nutrition Male 3.20 3.12
Female 3.49 3.23
Taking vitamins Male 3.10 2.73*
Female 3.46 3.38
Reducing smoking Male 3.38 3.18
Female 3.21 3.29
Controlled body weight Male 2.90* 3.17
Female 3.32 3.05
Exercise Male 3.08 3.05
Female 3.07 2.72
No effort Male 2.00 2.08
Female 1.77 2.13
*Significant at 0.05 level.
be that patients regard as the start of their disease the beginning
of their allergic symptoms “only” that preceded the disease.
Another problem is due to the fact that the source docu-
ment contains the first diagnosis in adulthood, which might be
a source of error if the patient was already diagnosed with asthma
in childhood.
The difference could be explained by a lengthy patient jour-
ney, too: the patient might visit several doctors between the first
symptoms and the setting up of the diagnosis, until he/she finally
arrives at the pulmonary center. For instance, a COPD patient
described that he/she visited several places starting from the
general practitioner, through laryngology and up to allergy exam-
ination for years with his/her coughing symptoms (coming off
with negative results from everywhere), until he/she accidentally
visited the lung center, where the disease was finally diagnosed
and the patient was taken into care.
More thought-provoking is the fact that half of the patients
began visiting a specialist later than the date of the first diagnosis
that we know. It may be that as much as even half of the patients
become seriously aware of their disease only later.
Table 6 | Efforts to maintain health according to the age of
respondents.
Asthma COPD
Less stressful lifestyle −40 years 3.08* **
41–60 years 3.70 3.44
61– years 3.77 3.56
Gave up smoking −40 years 3.47
41–60 years 3.35 2.78
61– years 3.57 3.71
Healthy nutrition −40 years 3.15
41–60 years 3.53 3.26
61– years 3.48 3.12
Taking vitamins −40 years 3.54
41–60 years 3.24 3.00
61– years 3.15 3.14
Reducing smoking −40 years 3.58
41–60 years 3.00 3.50
61– years 3.24 2.94
Controlled body weight −40 years 2.97
41–60 years 3.23 3.32
61– years 3.40 2.95
Exercise −40 years 2.94
41–60 years 3.13 2.78
61– years 3.24 3.00
No effort −40 years 1.83
41–60 years 1.97 2.10
61– years 1.70 2.05
*Significant at 0.05 level, **Not applicable because of the low number of respon-
dents (the total number of COPD-respondents younger than 40 years is 4).
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Table 7 | Efforts to maintain health according to the perceived
condition of asthma or COPD of respondents.
Asthma COPD
Less stressful lifestyle Controlled 2.58* 3.13
Partly controlled 3.47 3.65
Not controlled 3.69 3.42
Gave up smoking Controlled 4.08 2.88
Partly controlled 3.57 3.24
Not controlled 3.23 3.06
Healthy nutrition Controlled 3.75 2.63
Partly controlled 3.47 3.22
Not controlled 3.44 3.29
Taking vitamins Controlled 3.58 2.00
Partly controlled 3.06 3.26
Not controlled 3.43 3.19
Reducing smoking Controlled 3.78 3.14
Partly controlled 3.26 3.43
Not controlled 3.23 2.93
Controlled body weight Controlled 2.92 3.00
Partly controlled 3.27 3.08
Not controlled 3.20 3.15
Exercise Controlled 2.50 2.38
Partly controlled 3.21 2.97
Not controlled 3.10 2.94
No effort Controlled 2.00 2.50
Partly controlled 1.71 1.90
Not controlled 1.93 2.30
*Significant at 0.05 level.
One might look for reasons in the players themselves. The
question may be asked how much emphasis was laid by the spe-
cialist on sharing with the patients openly and in details the
essentials, nature, progress, expected consequences, perspectives
and treatment options of the disease at the time of setting up the
diagnosis. Given the statistics of patient turnover and the lack of
professionals one may guess that there are gaps in the doctors’
information sharing.
But when the data are examined from the aspect of the patient,
it seems as if the setting up of the diagnosis would only be a single
event for the patient, without any consequences (even if medica-
tion therapy has been ordered). It is a known fact that asthmatic
patients report their symptoms early (unlike the COPD patients),
because the first symptom in most cases is an asthmatic attack,
which is frightful for a lay person and the patient him/herself
experiences it as scary. When the patient receives help, although
diagnosis is given, if the patient is fully restored to health and can
perform daily activities without complaints, then his/her faith will
be strengthened that this attack was in fact a one-time event, just
a bad memory. The patient will typically accept the disease when
the problems reappear.
Thus, as regards perceived susceptibility and the acceptance
of the diagnosis, one may conclude based on responses given to
this group of questions that it takes a long time for the patient
after the appearance of the first complaints to get to a special-
ist, get and accept an accurate diagnosis, and accept the necessity
of regular treatment, check-ups, and follow-up. It is difficult for
the patient to accept that suddenly a change occurs in his/her
usual lifestyle and capabilities, which forces him/her to recon-
sider his/her work, lifestyle, his/her responsibility for him/herself
and his/her environment and the sources of risk that should be
avoided. This behavior is typical in general in the case of chronic
diseases.
However, it seems that once the patient got to the end of
this long journey (of recognition and acceptance), he/she will see
his/her limitations clearly, together with the causes and maintain-
ability of the disease.
Once the disease is accepted, the patients will understand what
they can expect, and more or less become familiar with their dis-
ease, the sources of risk to be avoided, and learn what to do when
a problem arises. They assess and understand that they have to
and can live with this disease. There will be better and worse peri-
ods in the progression of the disease, but living with the disease
can be made easier by the new “rules of the game,” changes in the
way of life and the lifestyle.
The fact that half of the patients felt the balancedness of
their disease was worse than what their actual breath function
results would suggest, could be explained by the fact that these
patients experience dyspnea episodes more often than the aver-
age, they have complaints more often (perhaps due to irregularity
in following the therapy), or they have not accepted the chang-
ing of their lifestyle yet. It may be concluded from this that
they use emergency (bronchodilator) medicinemore often, which
“improves” the control value, while the subjective value (showing
the experiences and observations of the past one month) remains
unchanged.
This implies that closer, more frequent or rather more thor-
ough contacts are necessary in order to enable the treatment
physician to control correct adherence to therapy.
FACTORS AND EFFECTS OF PERCEIVED BENEFITS AND BARRIERS
The group of patients we asked understand and know what they
should use and why in order to keep their disease in balance
and consider themselves self-confident in this knowledge. The
patient is content with the medicine products, because they are
received ready-made. The medicine has an exact dosage, and
the patient needs not make special effort to observe the rec-
ommended administration frequency and dose. However, the
modern product is insufficient for real management and keep-
ing in balance of the disease. Nevertheless, as soon as changes in
the lifestyle need to be made, we immediately see serious gaps in
adherence.
Half of the patients forget to take the medicine sometimes, we
cannot know how long the medicine is missed, nevertheless, it is
clear that there are adherence gaps in the taking of the medicine.
FACTORS OF CUES TO ACTION
Strong (paternalistic) attachment to the treatment physician: the
patient accepts everything that the doctor says and suggests,
the patient will not ask or object, he/she will not have a say in
the treatment as prescribed by the doctor. In addition to powerful
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attachment, there is a strong reliance, too, as the patient will visit
the doctor without delay in case of a problem (the patient will visit
the doctor and not look for other ways) and will expect all infor-
mation to be given personally by the doctor. This result shows
the importance of the regular contacts with the doctors, but it
shows also that the patients are expecting much help from the
doctor.
The patients expect information on everything, but incon-
sistently they entrust all decisions related to their care to their
doctor, as the patient cannot understand everything, anyway.
Patients claim they are interested in everything that is related to
their health and disease, yet the sources of obtaining the informa-
tion vary greatly. They consider the doctor to be the surest source
of information, that is why patient education by the doctor is so
very important.
Although the patient often feels abandoned, the self-organized
patient groups and patient clubs, if any, carry little significance, as
patients are less interested in participating. This is partly associ-
ated with the general patient culture and also the local healthcare
system.
One reason for the self-organized patient communities could
be to teach patients how to ask questions, how to argue (in the
right sense of the word) with the treatment physician, so that all
problems and fears—that might induce poor adherence—come
to the surface.
Explaining and learning to ask—the physician has also some-
thing to learn in this area. There is high need for simple explana-
tions, and the doctor should explain to the patient what is useful
and why and what needs to be done, by showing levels of cause
and effect. In addition to information sharing, it is very impor-
tant also to check if the patient really understood what is to be
done.
FACTORS OF SELF EFFICACY
The responses given to the last question in this group are rather
contradictory. The patients request (and expect) full information,
because they feel this is how they can participate responsibly in
their healing, but at the same time they fully rely on the doctor
(and so paternalism will prevail in the end).
This is thought-provoking also because although the patient
expects information sharing as a passive process whereby a set
of information is poured into his/her head, which is not up to
him/her to initiate, if possible, but it is best done by the treatment
physician on his/her own initiative.
The attitude analysis revealed similar characteristics in the case
of the COPD patients, too.
The patients are more willing to move—at least initially—in
the direction of actions that require less energy invested. It is
easier to say that they strive for what is good and healthy, but
regular exercise is not a popular choice (although according to the
latest scientific developments a combination of pharmacother-
apy and exercise training for respiratory rehabilitation is a real
breakthrough in the treatment of COPD).
Attachment to the treatment physician is powerful among the
COPD patients, too; he/she is contacted and sought when there
is a problem. Anticipation of full information from the doctor
and reliance on the doctor are apparently opposing notions, but
in my opinion, like in the case of asthmatic patients, here again
the patient expects passive information receiving and not a joint
decision or agreement based on discussion.
In respect of the cues to action and self-efficacy as analyzed in
the model, in other words in respect of what those suffering in
these two chronic diseases are willing to carry out for the sake
of their own health, no significant correlation can be demon-
strated according to the demographic variants. The results are
similar in the literature, and where a correlation is manifested
with the demographic variants, this correlation is still unclear.
(Howell, 2008) in his research shows a difference between the
sexes, such as the women are more inclined to non-adherence,
but this difference disappears with age (Lemmens, 2009).
Non-adherence is not significantly related to the type or sever-
ity of disease, with rates of between 25 and 30% noted across 17
disease conditions (DiMatteo, 2004).
CONCLUSIONS
Our aim was to analyse the factors of health behavior influenc-
ing patient adherence in asthma and COPD. We can confirm the
results in the literature according to the few relationships among
socio-demographic variables and behavioral variables and the
factors of adherence. Because of the limitations of the research the
results and the possible conclusions have explorative character.
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APPENDIX A
Table A1 | Levels of asthma control.






























Table A2 | Classification of severity of airflow limitation in COPD
(based on post-Bronchodilator FEV1).
GOLD 1 GOLD 2 GOLD 3 GOLD 4
Mild Moderate Severe Very Severe
FEV1 > 80%
predicted
50% < FEV1 < 80%
predicted






The ASTHM A CONTROL TEST™ is a quick test for people
with asthma 12 years and older. It provides a numerical score to
help assess asthma control.
INSTRUCTIONS:
1. Write the number of each answer in the score box provided.
2. Add up the score boxes to get the TOTAL.
3. Discuss your results with your doctor.
Name: Today’s Date:
1. In the past 4 weeks, how much of time did your asthma keep
you from getting as much done at work, school or at home?
SCORE . . . . . .
All of the time [1]
Most of the time [2]
Some of the time [3]
A little of the time [4]
None of the time [5]
2. During the past 4 weeks, how often have you had shortness of
breath?
SCORE . . . . . .
4 or more nights a week [1]
2 or 3 nights a week [2]
Once a week [3]
Once or twice [4]
Not at all [5]
3. During the past 4 weeks, how often did your asthma symp-
toms (wheezing, coughing, shortness of breath, chest tightness
or pain) wake you up at night or earlier than usual in the
morning?
SCORE . . . . . .
4 or more times per day [1]
1 or 2 times per day [2]
2 or 3 times per week [3]
Once a week or less [4]
Not at all [5]
4. During the past 4 weeks, how often have you used your rescue
inhaler or nebulizer medication (such as albuterol)?
SCORE . . . . . .
3 or more times per day [1]
1 or 2 times per day [2]
2 or 3 times per week [3]
Once a week or less [4]
Not at all [5]
5. 5. How would you rate your asthma control during the past 4
weeks?
SCORE . . . . . .





If your score is 19 or less, your asthma may not be as well
controlled as it could be.
No matter what your score is, share the results with your
healthcare provider.
TOTAL:. . . . . .
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